Home Cart 0 Sign in  
X

[ CAS No. 2174-58-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 2174-58-5
Chemical Structure| 2174-58-5
Chemical Structure| 2174-58-5
Structure of 2174-58-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 2174-58-5 ]

Related Doc. of [ 2174-58-5 ]

Alternatived Products of [ 2174-58-5 ]

Product Details of [ 2174-58-5 ]

CAS No. :2174-58-5 MDL No. :MFCD00192321
Formula : C5H8O4 Boiling Point : -
Linear Structure Formula :- InChI Key :WXUAQHNMJWJLTG-VKHMYHEASA-N
M.W : 132.11 Pubchem ID :6950476
Synonyms :

Calculated chemistry of [ 2174-58-5 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.6
Num. rotatable bonds : 3
Num. H-bond acceptors : 4.0
Num. H-bond donors : 2.0
Molar Refractivity : 29.69
TPSA : 74.6 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.25 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.52
Log Po/w (XLOGP3) : -0.21
Log Po/w (WLOGP) : 0.18
Log Po/w (MLOGP) : -0.13
Log Po/w (SILICOS-IT) : -0.46
Consensus Log Po/w : -0.02

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -0.33
Solubility : 62.0 mg/ml ; 0.469 mol/l
Class : Very soluble
Log S (Ali) : -0.9
Solubility : 16.6 mg/ml ; 0.126 mol/l
Class : Very soluble
Log S (SILICOS-IT) : 0.57
Solubility : 487.0 mg/ml ; 3.69 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.82

Safety of [ 2174-58-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 2174-58-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 2174-58-5 ]

[ 2174-58-5 ] Synthesis Path-Downstream   1~88

  • 1
  • [ 2174-58-5 ]
  • [ 6973-20-2 ]
YieldReaction ConditionsOperation in experiment
100% With acetyl chloride; for 3h;Reflux; <strong>[2174-58-5](S)-(-)-methyl succinic acid</strong> (10.0 mmol) and acetyl chloride (30.0 mmol) wereplaced in a single neck round bottomed flask and the assembly was refluxedon the steam bath for 3 h. The solution is allowed to cool undisturbed and is finally chilled in an ice bath. The succinic anhydride, which separates inbeautiful crystals, is collected on a Buchner funnel, washed with two 75-cc.portions of cold ether, and dried in a vacuum desiccator.TLC: 0.54 (Petroleum ether/EtOAc, 6:4)Yield: 100%[alpha]D2G = -11.0 (c 1, CHCb)MS (ESI) mjz calculated for CsH603 [M+Na]+: 137.12, founcl137.101H NMR (500 MHz, CDCb): 8 3.48 (h, J = 6.9 Hz, 1H), 3.02 (del, J = 18.2, 7.0Hz, 1H), 2.56 (del, J = 18.2, 7.0 Hz, 1H), 1.17 (cl, J = 6.8 Hz, 3H).l:3C NMR (100 MHz, CDCb): 8 176.8, 172.9, 35.0, 30.3, 15.1.
80% With acetyl chloride; at 60℃; for 3h; General procedure: (R)-(+)-methylsuccinic acid 9 (0.5 g, 3.78 mmol) and acetyl chloride (0.81 mL, 11.35 mmol) were heated to 60 C for 3 hours. Solvent was removed and the resulting solid was washed with cold ether. The precipitate was collected and dried under vacuum to give (3R)-3-methyltetrahydrofuran-2,5-dione. (S)-3-methyltetrahydrofuran-2,5-dione (11a). Synthesized as previously described for the R-enantiomer starting with <strong>[2174-58-5](S)-(-)-methylsuccinic acid</strong> (2.0 g, 15.14 mmol) to give (S)-3-methyltetrahydrofuran-2,5-dione (1.38 g, 12.10 mmol, 80% yield) as a white crystalline solid (mp 66.3-68.0 C).
With trifluoroacetic anhydride; for 3h;Cooling with ice; To the compound 53a (13.8 g, 104 mmol), trifluoroacetic anhydride (17.7 mL, 125 mmol) was added under icecooling. Under ice cooling, the mixture was stirred for 3 hours and then concentrated under reduced pressure. Toluenewas added to the residue. The mixture was concentrated again under reduced pressure to afford the compound 53b.The obtained compound 53b was used directly in the next reaction without being purified.
With trifluoroacetic anhydride; for 3h;Cooling with ice; To the compound 53a (13.8 g, 104 mmol), trlfluoroacetlc anhydrlde (17.7 ml, 125 mmol) was added under lcecoollng. Under lce coollng, the mlxture was stlrred for 3 hours and then concentrated under reduced pressure. Toluenewas added to the resldue. The mlxture was concentrated agaln under reduced pressure to afford the compound 53b.The obtalned compound 53b was used dlrectly ln the next reactlon wlthout belng purlfled.
With trifluoroacetic anhydride; for 3h;Cooling with ice; In compound 75a (13.8 g, 104 mmol),Trifluoroacetic anhydride (17.7 mL, 125 mmol) was added under ice-cooling.After stirring for 3 hours under ice cooling, the solution was concentrated under reduced pressure. Add toluene to the residue,Compound 75b was obtained by concentrating again under reduced pressure.The obtained compound 75b was used in the subsequent reaction without purification.To a solution of the entire amount of the obtained compound 75b in tetrahydrofuran (64 mL) was added p-methoxybenzyl alcohol (23.2 g, 168 mmol) and DMAP (1.37 g, 11.2 mmol).Heat to reflux for 6 hours.After the reaction mixture was concentrated under reduced pressure,To the residue were added an aqueous sodium hydrogen carbonate solution and ethyl acetate, and the aqueous layer was separated.After adding 2 mol / L hydrochloric acid to the separated aqueous layer to pH = 2,Extraction was performed with ethyl acetate. Wash the organic layer with water and saturated brine,Drying over anhydrous magnesium sulfate. After filtering,The filtrate was concentrated under reduced pressure to obtain compounds 75c and 75c-ii as a colorless oil.(21 g, 74% yield).

  • 2
  • [ 61713-72-2 ]
  • [ 2174-58-5 ]
  • 5
  • [ 498-23-7 ]
  • [ 2174-58-5 ]
  • 6
  • [ 498-21-5 ]
  • [ 2174-58-5 ]
  • 7
  • [ 97-65-4 ]
  • [ 3641-51-8 ]
  • [ 2174-58-5 ]
YieldReaction ConditionsOperation in experiment
Example 59; Asymmetric hydrogenation of itaconic acid [Show Image] Under an argon atmosphere, to bis(eta2,eta2-1,5-cyclooctadiene)rhodium(I) trifluoromethanesulfonate (1.0 mg, 0.0021 mmol) and (S)-2,2'-bis[bis(4-dimethylaminophenyl)phosphino]-1,1'-binaphthyl (4.6 mg, 0.0058 mmol) synthesized in Reference Example 8 was added methanol (4 mL), and the mixture was stirred for 30 min. The reaction mixture was added to a solution of itaconic acid (21.8 mg, 0.168 mmol) in methanol (1 mL), and the mixture was subjected to hydrogenation under a 1 MPa hydrogen pressure at 25C for 15 hr. 2 mL of the reaction mixture was taken, sulfuric acid was added and the mixture was refluxed at 85C for 1 hr. The methylated solution was analyzed by gas chromatography (column: betaDEX-225 (0.25 mm i.d. × 30 m, 0.25 mum)) to find a conversion ratio of 100%, and an optical purity of 56.2%ee.
Comparative Example 5; Asymmetric hydrogenation of itaconic acid [Show Image] According to the method of Example 57, the reaction was carried out using (S)-2,2'-bis[diphenylphosphino]-1,1'-binaphthyl (BINAP) as a ligand. As a result, the conversion ratio was 100% and the optical purity was 6.9%ee(R).
Example 59; Asymmetric hydrogenation of itaconic acid [Show Image] Under an argon atmosphere, to bis(eta2,eta2-1,5-cyclooctadiene)rhodium(I) trifluoromethanesulfonate (1.0 mg, 0.0021 mmol) and (S)-2,2'-bis[bis(4-dimethylaminophenyl)phosphino]-1,1'-binaphthyl (4.6 mg, 0.0058 mmol) synthesized in Reference Example 8 was added methanol (4 mL), and the mixture was stirred for 30 min. The reaction mixture was added to a solution of itaconic acid (21.8 mg, 0.168 mmol) in methanol (1 mL), and the mixture was subjected to hydrogenation under a 1 MPa hydrogen pressure at 25C for 15 hr. 2 mL of the reaction mixture was taken, sulfuric acid was added and the mixture was refluxed at 85C for 1 hr. The methylated solution was analyzed by gas chromatography (column: betaDEX-225 (0.25 mm i.d. × 30 m, 0.25 mum)) to find a conversion ratio of 100%, and an optical purity of 56.2%ee. Examples 60-63 According to the method of Example 59, the reaction was carried out using the optically active ligands of Examples 3, 6, 12 and 15. The results are shown in Table 2.
Example 59; Asymmetric hydrogenation of itaconic acid [Show Image] Under an argon atmosphere, to bis(eta2,eta2-1,5-cyclooctadiene)rhodium(I) trifluoromethanesulfonate (1.0 mg, 0.0021 mmol) and (S)-2,2'-bis[bis(4-dimethylaminophenyl)phosphino]-1,1'-binaphthyl (4.6 mg, 0.0058 mmol) synthesized in Reference Example 8 was added methanol (4 mL), and the mixture was stirred for 30 min. The reaction mixture was added to a solution of itaconic acid (21.8 mg, 0.168 mmol) in methanol (1 mL), and the mixture was subjected to hydrogenation under a 1 MPa hydrogen pressure at 25C for 15 hr. 2 mL of the reaction mixture was taken, sulfuric acid was added and the mixture was refluxed at 85C for 1 hr. The methylated solution was analyzed by gas chromatography (column: betaDEX-225 (0.25 mm i.d. × 30 m, 0.25 mum)) to find a conversion ratio of 100%, and an optical purity of 56.2%ee. Examples 60-63 According to the method of Example 59, the reaction was carried out using the optically active ligands of Examples 3, 6, 12 and 15. The results are shown in Table 2.
Example 59; Asymmetric hydrogenation of itaconic acid [Show Image] Under an argon atmosphere, to bis(eta2,eta2-1,5-cyclooctadiene)rhodium(I) trifluoromethanesulfonate (1.0 mg, 0.0021 mmol) and (S)-2,2'-bis[bis(4-dimethylaminophenyl)phosphino]-1,1'-binaphthyl (4.6 mg, 0.0058 mmol) synthesized in Reference Example 8 was added methanol (4 mL), and the mixture was stirred for 30 min. The reaction mixture was added to a solution of itaconic acid (21.8 mg, 0.168 mmol) in methanol (1 mL), and the mixture was subjected to hydrogenation under a 1 MPa hydrogen pressure at 25C for 15 hr. 2 mL of the reaction mixture was taken, sulfuric acid was added and the mixture was refluxed at 85C for 1 hr. The methylated solution was analyzed by gas chromatography (column: betaDEX-225 (0.25 mm i.d. × 30 m, 0.25 mum)) to find a conversion ratio of 100%, and an optical purity of 56.2%ee. Examples 60-63 According to the method of Example 59, the reaction was carried out using the optically active ligands of Examples 3, 6, 12 and 15. The results are shown in Table 2.
Example 59; Asymmetric hydrogenation of itaconic acid [Show Image] Under an argon atmosphere, to bis(eta2,eta2-1,5-cyclooctadiene)rhodium(I) trifluoromethanesulfonate (1.0 mg, 0.0021 mmol) and (S)-2,2'-bis[bis(4-dimethylaminophenyl)phosphino]-1,1'-binaphthyl (4.6 mg, 0.0058 mmol) synthesized in Reference Example 8 was added methanol (4 mL), and the mixture was stirred for 30 min. The reaction mixture was added to a solution of itaconic acid (21.8 mg, 0.168 mmol) in methanol (1 mL), and the mixture was subjected to hydrogenation under a 1 MPa hydrogen pressure at 25C for 15 hr. 2 mL of the reaction mixture was taken, sulfuric acid was added and the mixture was refluxed at 85C for 1 hr. The methylated solution was analyzed by gas chromatography (column: betaDEX-225 (0.25 mm i.d. × 30 m, 0.25 mum)) to find a conversion ratio of 100%, and an optical purity of 56.2%ee. Examples 60-63 According to the method of Example 59, the reaction was carried out using the optically active ligands of Examples 3, 6, 12 and 15. The results are shown in Table 2.
Beispiel 6 : Herstellung der Rh-Komplexes Zu einer Loesung von 1 mmol des Diphosphines (Beispiel 5) in 2 [ML] THF werden 1 mmol [Rh (COD) acac] gegeben und die Loesung 15 min geruehrt. Im Anschluss wird eine aequimolare Menge 40% ige [TETRAFLUORBORONSaeURE] zugegeben und weitere 15 min geruehrt. Der Metallkomplex wird durch Zugabe von 20 ml Ether ausgefaellt, durch Zugabe von 0.5 [ML DICHLORMETHAN] wieder geloest und durch Zugabe von Ether erneut ausgefaellt. Der Metallkomplex wird abfiltriert und im Vakuum getrocknet. [P-NMR (CDC13)] : [8 = 22.] 3 (dd), 16.7 (dd) ppm. Beispiel 7 : Hydrierungen Alle Hydrierungen wurden bei [25C] unter einem Wasserstoffdruck von 1 bar in 15 ml Loesungsmittel durchgefuehrt. Substrat und Katalysator (Beispiel 6) wurden im Verhaeltnis 100 : 1 eingesetzt.
Beispiel 6 : Herstellung der Rh-Komplexes Zu einer Loesung von 1 mmol des Diphosphines (Beispiel 5) in 2 [ML] THF werden 1 mmol [Rh (COD) acac] gegeben und die Loesung 15 min geruehrt. Im Anschluss wird eine aequimolare Menge 40% ige [TETRAFLUORBORONSaeURE] zugegeben und weitere 15 min geruehrt. Der Metallkomplex wird durch Zugabe von 20 ml Ether ausgefaellt, durch Zugabe von 0.5 [ML DICHLORMETHAN] wieder geloest und durch Zugabe von Ether erneut ausgefaellt. Der Metallkomplex wird abfiltriert und im Vakuum getrocknet. [P-NMR (CDC13)] : [8 = 22.] 3 (dd), 16.7 (dd) ppm. Beispiel 7 : Hydrierungen Alle Hydrierungen wurden bei [25C] unter einem Wasserstoffdruck von 1 bar in 15 ml Loesungsmittel durchgefuehrt. Substrat und Katalysator (Beispiel 6) wurden im Verhaeltnis 100 : 1 eingesetzt.
With hydrogen;Rh-complex of (R,R)-DiPAMP; In methanol; at 20℃; under 760.051 Torr; for 0.666667h;Product distribution / selectivity; To a solution of the substrate (0.5 mmol) in MeOH (7 ml), a solution of the Rh-L* catalyst in MeOH (prepared as above) is added under Ar, then a vacuum/H2 cycle is applied. The mixture is stirred at room temperature under 1 atm of H2 (10 bars for atropic acid) until uptake H2 ceased. The solution is analyzed by GC on Lipodex E, Chiralsil-L-Val, CP-Chiralsil DEX CB columns. The acids were esterified in CH2Cl2 using TMSCH2N2 (hexanes) prior to analysis 25 (Tables 4, 5 and 6). The results show that using the ligands of the present invention, it is possible to significantly increase the reaction rate and the ee of the product.
With hydrogen;[(eta2-1,2,5,6)-1,5-cyclooctadiene][(Sp,S)-cis-2-(2-diphenylphosphinoethyl-kappaP)-(1-phenylphospholane-kappaP)]rhodium(I)hexafluoroantimonate; In methanol; at 20℃; for 3h;Product distribution / selectivity; In a glove box, an autoclave with a 20 mL glass tube insert equipped with a magnetic stirring bar was charged with the hydrogenation substrate (1 mmol), anhydrous degassed solvent (7 mL) and the metal complex pre-catalyst (0.01 mmol). After 10 cycles of evacuation and filling with hydrogen, the autoclave was pressurised to an appropriate initial pressure of hydrogen. The reaction mixture was stirred at room temperature and after the appropriate time the autoclave was opened, the reaction mixture was filtered through silica gel, concentrated and the residue was analysed by enantioselective GC.
With hydrogen;[(eta2-1,2,5,6)-1,5-cyclooctadiene][(Sp,R)-trans-2-(2-diphenylphosphinoethyl-kappaP)-(1-phenylphospholane-kappaP)]rhodium(I)hexafluoroantimonate; In methanol; at 20℃; for 3h;Product distribution / selectivity; In a glove box, an autoclave with a 20 mL glass tube insert equipped with a magnetic stirring bar was charged with the hydrogenation substrate (1 mmol), anhydrous degassed solvent (7 mL) and the metal complex pre-catalyst (0.01 mmol). After 10 cycles of evacuation and filling with hydrogen, the autoclave was pressurised to an appropriate initial pressure of hydrogen. The reaction mixture was stirred at room temperature and after the appropriate time the autoclave was opened, the reaction mixture was filtered through silica gel, concentrated and the residue was analysed by enantioselective GC.
With hydrogen;[(eta2-1,2,5,6)-1,5-cyclooctadiene][(Sp,R,R)-trans-2-(2-diphenylphosphino-2-methylethyl-kappaP)-(1-phenylphospholane-kappaP)]rhodium(I)hexafluoroantimonate; In methanol; at 20℃; for 3h;Product distribution / selectivity; In a glove box, an autoclave with a 20 mL glass tube insert equipped with a magnetic stirring bar was charged with the hydrogenation substrate (1 mmol), anhydrous degassed solvent (7 mL) and the metal complex pre-catalyst (0.01 mmol). After 10 cycles of evacuation and filling with hydrogen, the autoclave was pressurised to an appropriate initial pressure of hydrogen. The reaction mixture was stirred at room temperature and after the appropriate time the autoclave was opened, the reaction mixture was filtered through silica gel, concentrated and the residue was analysed by enantioselective GC.
With hydrogen;[(eta2-1,2,5,6)-1,5-cyclooctadiene][(Sp,R,S)-trans-2-(2-diphenylphosphino-2-methylethyl-kappaP)-(1-phenylphospholane-kappaP)]rhodium(I)hexafluoroantimonate; In tetrahydrofuran; at 20℃; for 3h;Product distribution / selectivity; In a glove box, an autoclave with a 20 mL glass tube insert equipped with a magnetic stirring bar was charged with the hydrogenation substrate (1 mmol), anhydrous degassed solvent (7 mL) and the metal complex pre-catalyst (0.01 mmol). After 10 cycles of evacuation and filling with hydrogen, the autoclave was pressurised to an appropriate initial pressure of hydrogen. The reaction mixture was stirred at room temperature and after the appropriate time the autoclave was opened, the reaction mixture was filtered through silica gel, concentrated and the residue was analysed by enantioselective GC.
With hydrogen;[(eta2-1,2,5,6)-1,5-cyclooctadiene][(Sp,R)-trans-2-(2-diphenylphosphinoethyl-kappaP)-(1-phenylphospholane-kappaP)]rhodium(I)tetrafluoroborate; at 20℃; for 3h;Product distribution / selectivity; In a glove box, an autoclave with a 20 mL glass tube insert equipped with a magnetic stirring bar was charged with the hydrogenation substrate (1 mmol), anhydrous degassed solvent (7 mL) and the metal complex pre-catalyst (0.01 mmol). After 10 cycles of evacuation and filling with hydrogen, the autoclave was pressurised to an appropriate initial pressure of hydrogen. The reaction mixture was stirred at room temperature and after the appropriate time the autoclave was opened, the reaction mixture was filtered through silica gel, concentrated and the residue was analysed by enantioselective GC.
With hydrogen;[(eta2-1,2,5,6)-1,5-cyclooctadiene][(Sp,S)-cis-2-(2-diphenylphosphinoethyl-kappaP)-(1-phenylphospholane-kappaP)]rhodium(I)tetrafluoroborate; at 20℃; for 3h;Product distribution / selectivity; In a glove box, an autoclave with a 20 mL glass tube insert equipped with a magnetic stirring bar was charged with the hydrogenation substrate (1 mmol), anhydrous degassed solvent (7 mL) and the metal complex pre-catalyst (0.01 mmol). After 10 cycles of evacuation and filling with hydrogen, the autoclave was pressurised to an appropriate initial pressure of hydrogen. The reaction mixture was stirred at room temperature and after the appropriate time the autoclave was opened, the reaction mixture was filtered through silica gel, concentrated and the residue was analysed by enantioselective GC.
With chloro(1,5-cyclooctadiene)rhodium(I) dimer; (2S,4S)-N-butoxycarbonyl-4-diphenylphosphino-2-diphenylphosphinomethylpyrrolidine; In water; at 30℃; under 825.083 Torr;Catalytic behavior; General procedure: The set up of the hydrogenation apparatus [22,23] is shown in Scheme 4. About 1.0-1.4 g of the yellow-orange sol gel immobilized catalyst, a desired amount of substrate and 95 mL of solvent (methanol, water or aqueous-micellar solution) were added to a stirred tank reactor and stirred at 400 rpm under N2-atmosphere at the desired reaction temperature. The N2 was replaced by H2 (p = 1.1 × 105 Pa) without stirring and the reaction was started by turning the stirrer on 800 rpm again. The reactions were performed in semi-batch mode with hydrogen being permanently added to the stirred tank reactor to achieve a constant total pressure of 1.1 × 105 Pa in reactor. The cumulative hydrogen consumption and the pressure during the reaction were recorded using a Bronkhorst flow meter and pressure controller (Bronkhorst Maettig GmbH, Kamen, Germany), respectively (see Scheme 4). The sensitivity of measured hydrogen consumption was ±0.4 mL. The pressure and the hydrogen flow during the reaction were registered and analyzed on a PC, from these results the substrate concentration csubstrate and the conversion X were calculated.
With C18H16F6N2O4Pd; hydrogen; benzylamine; In 2,2,2-trifluoroethanol; at 20℃; under 5171.62 Torr; General procedure: The corresponding Pd complex (0.05 mmol) was dissolved inthe reactor with the proper amount of MeOH or TFE. The prochiralsubstrate (10 mmol), IA or AA, was then added to the reactor. Insome cases BA (0.05 mmol) was used as an additive. Finally, thereactor was flushed 5 times with pure H2 before setting the pressureto 100 psi. Samples (0.15 mL) were drawn from the reactor to followthe reaction as a function of time.

Reference: [1]Tetrahedron Letters,1987,vol. 28,p. 1905 - 1908
[2]Bulletin of the Chemical Society of Japan,1986,vol. 59,p. 175 - 178
[3]Journal of Organometallic Chemistry,1990,vol. 387,p. 209 - 217
[4]European Journal of Inorganic Chemistry,2000,p. 2011 - 2016
[5]Tetrahedron Asymmetry,1991,vol. 2,p. 331 - 334
[6]Chemistry Letters,1983,p. 1203 - 1206
[7]Chemical and pharmaceutical bulletin,1985,vol. 33,p. 5284 - 5293
[8]Angewandte Chemie,1988,vol. 100,p. 1231 - 1232
[9]Zeitschrift fur Chemie,1984,vol. 24,p. 405 - 406
[10]Bulletin of the Chemical Society of Japan,1980,vol. 53,p. 2012 - 2015
[11]Tetrahedron Asymmetry,1992,vol. 3,p. 13 - 16
[12]Journal of Organometallic Chemistry,1992,vol. 435,p. 133 - 147
[13]Chemical and Pharmaceutical Bulletin,1991,vol. 39,p. 2767 - 2769
[14]Tetrahedron Asymmetry,1994,vol. 5,p. 675 - 690
[15]Bulletin of the Chemical Society of Japan,1984,vol. 57,p. 2171 - 2176
[16]Heterocycles,1990,vol. 31,p. 1413 - 1416
[17]Journal of Organometallic Chemistry,1990,vol. 387,p. 209 - 217
[18]Tetrahedron Letters,1988,vol. 29,p. 4755 - 4758
[19]Tetrahedron Letters,1989,vol. 30,p. 735 - 738
[20]Journal of the Chemical Society. Perkin transactions I,1989,p. 1571 - 1575
[21]Chemistry Letters,1989,p. 559 - 562
[22]Chemical and Pharmaceutical Bulletin,1993,vol. 41,p. 1149 - 1156
[23]Journal of Organometallic Chemistry,1992,vol. 435,p. 133 - 147
[24]Journal of Organometallic Chemistry,1992,vol. 428,p. 155 - 167
[25]Journal of Organometallic Chemistry,1989,vol. 370,p. C9 - C12
[26]Journal of Organometallic Chemistry,1985,vol. 288,p. C37 - C40
[27]Bulletin of the Chemical Society of Japan,1984,vol. 57,p. 2171 - 2176
[28]Tetrahedron Asymmetry,1995,vol. 6,p. 1973 - 1988
[29]Chemistry - A European Journal,1997,vol. 3,p. 1365 - 1369
[30]Chemical Communications,1997,p. 1713 - 1714
[31]Chemistry - A European Journal,1998,vol. 4,p. 769 - 771
[32]Heterocycles,1990,vol. 31,p. 1413 - 1416
[33]Journal of Organometallic Chemistry,1990,vol. 387,p. 209 - 217
[34]Chemische Berichte,1990,vol. 123,p. 847 - 853
[35]Tetrahedron Letters,1988,vol. 29,p. 4755 - 4758
[36]Synthesis,1989,p. 743 - 745
[37]Angewandte Chemie,1988,vol. 100,p. 1231 - 1232
[38]Chemistry Letters,1989,p. 559 - 562
[39]Bulletin of the Chemical Society of Japan,1984,vol. 57,p. 739 - 746
[40]Journal of Organometallic Chemistry,1985,vol. 288,p. C37 - C40
[41]Bulletin of the Chemical Society of Japan,1986,vol. 59,p. 175 - 178
[42]Canadian Journal of Chemistry,1998,vol. 76,p. 1447 - 1456
[43]Journal of Organic Chemistry,1999,vol. 64,p. 9381 - 9385
[44]Tetrahedron Letters,2000,vol. 41,p. 3323 - 3326
[45]European Journal of Organic Chemistry,2000,p. 2885 - 2891
[46]European Journal of Organic Chemistry,2000,p. 2893 - 2899
[47]Journal of Organometallic Chemistry,2001,vol. 627,p. 37 - 43
[48]Dalton Transactions,2002,p. 752 - 758
[49]Chemical Communications,2002,p. 480 - 481
[50]Angewandte Chemie - International Edition,2002,vol. 41,p. 612 - 614
[51]Russian Chemical Bulletin,2001,vol. 50,p. 1860 - 1866
[52]Tetrahedron Asymmetry,2002,vol. 13,p. 1039 - 1042
[53]Tetrahedron,2002,vol. 58,p. 5895 - 5904
[54]European Journal of Inorganic Chemistry,2002,p. 2614 - 2624
[55]Tetrahedron Asymmetry,2003,vol. 14,p. 2739 - 2745
[56]Russian Journal of Organic Chemistry,2003,vol. 39,p. 926 - 932
[57]Tetrahedron Asymmetry,2003,vol. 14,p. 3253 - 3256
[58]European Journal of Organic Chemistry,2003,p. 3453 - 3459
[59]Tetrahedron Letters,2004,vol. 45,p. 7379 - 7381
[60]Tetrahedron Asymmetry,2004,vol. 15,p. 1673 - 1676
[61]Chemical Communications,2004,p. 1236 - 1237
[62]Dalton Transactions,2004,p. 1901 - 1905
[63]Chemical and Pharmaceutical Bulletin,2004,vol. 52,p. 1367 - 1371
[64]Dalton Transactions,2005,p. 2557 - 2562
[65]Tetrahedron Asymmetry,2005,vol. 16,p. 3640 - 3649
[66]Chemical Communications,2005,p. 6026 - 6028
[67]Chemistry - A European Journal,2007,vol. 13,p. 2798 - 2804
[68]Patent: EP1927596,2008,A1 .Location in patent: Page/Page column 44
[69]Patent: EP1927596,2008,A1 .Location in patent: Page/Page column 45
[70]Patent: EP1927596,2008,A1 .Location in patent: Page/Page column 44
[71]Patent: EP1927596,2008,A1 .Location in patent: Page/Page column 44
[72]Patent: EP1927596,2008,A1 .Location in patent: Page/Page column 44
[73]Patent: EP1927596,2008,A1 .Location in patent: Page/Page column 44
[74]Patent: WO2003/99832,2003,A1 .Location in patent: Page 12, 13
[75]Patent: WO2003/99832,2003,A1 .Location in patent: Page 12, 13
[76]Patent: US2010/99875,2010,A1 .Location in patent: Page/Page column 22
[77]Tetrahedron Asymmetry,2010,vol. 21,p. 1206 - 1209
[78]Patent: US2007/100152,2007,A1 .Location in patent: Page/Page column 24
[79]Patent: US2007/100152,2007,A1 .Location in patent: Page/Page column 24
[80]Patent: US2007/100152,2007,A1 .Location in patent: Page/Page column 24
[81]Patent: US2007/100152,2007,A1 .Location in patent: Page/Page column 24
[82]Patent: US2007/100152,2007,A1 .Location in patent: Page/Page column 25
[83]Patent: US2007/100152,2007,A1 .Location in patent: Page/Page column 25
[84]Patent: US2007/155974,2007,A1 .Location in patent: Page/Page column 6
[85]Patent: US2007/155974,2007,A1 .Location in patent: Page/Page column 6
[86]Tetrahedron Letters,2012,vol. 53,p. 4900 - 4902
[87]Journal of Molecular Catalysis A: Chemical,2013,vol. 366,p. 359 - 367
[88]Catalysis Letters,2013,vol. 143,p. 539 - 546
[89]Catalysis Today,2013,vol. 213,p. 109 - 114
[90]Journal of Physical Organic Chemistry,2012,vol. 25,p. 1006 - 1011
[91]Journal of Physical Organic Chemistry,2012,vol. 25,p. 1006 - 1011
[92]Green Chemistry,2015,vol. 17,p. 1702 - 1709
  • 8
  • [ 97-65-4 ]
  • [ 2174-58-5 ]
YieldReaction ConditionsOperation in experiment
With hydrogen;di(norbornadiene)rhodium(I) tetrafluoroborate; (R)-O,O'-(9,9'-spirobixanthene-1,1'-diyl)-N,N-dimethylphosphoramidite; In dichloromethane; at 20℃; under 1292.9 Torr; for 12h;Autoclave;Product distribution / selectivity; A solution of [Rh(nbd)2]BF4 (0.374 mg, 0.001 mmol) and ligand (R)-3 (1.0 mg, 0.0022 mmol) in CH2Cl2 (0.5 mL) was stirred in a glove-box for 10 min to allow the catalyst precursor to form. Then it was added into the solution of substrate (0.1 mmol) in 2.5 mL of CH2Cl2. Hydrogenation was performed in an autoclave with 25 psi of H2 at room temperature for 12 hours. After releasing H2, the reaction mixture was passed through a short silica gel plug to remove the catalyst. The concentrated solution was used for chiral GC to measure the enantiomeric excess. For hydrogenation of itaconic acid, the ee was determined by its corresponding dimethyl ester.
> 99%Spectr. With hydrogen;catalyst obtained in Preparation Example 7; In tetrahydrofuran; ethanol; at 50℃; under 2280.15 Torr; for 18h;autoclave;Product distribution / selectivity; A solution of an itaconic acid (40.9 mg, 0.314 mmol) dissolved in tetrahydrofuran (THF) (0.3 mL) and ethanol (EtOH) (0.3 mL) is added to an autoclave in which the catalyst obtained in Preparation Example 7 was added. After replacing the atmosphere to hydrogen gas, it was stirred for 18 hours at reaction temperature of 50 C. under 3 atm pressure of hydrogen. After the reaction, it was cooled down to be room temperature, and the catalyst was filtered in the atmosphere to recover thereof and washed with THF (1 mL) three times. The solvent was concentrated from the filtrate, and the desired (S)-2-methylsuccinic acid was obtained. The yield thereof measured by NMR was >99%, and the optical purity thereof was >90% ee.
With hydrogen;[(eta2-1,2,5,6)-1,5-cyclooctadiene][(Sp,R,R)-trans-2-(2-diphenylphosphino-2-methylethyl-kappaP)-(1-phenylphospholane-kappaP)]rhodium(I)hexafluoroantimonate; In tetrahydrofuran; at 20℃; for 3h;Product distribution / selectivity; In a glove box, an autoclave with a 20 mL glass tube insert equipped with a magnetic stirring bar was charged with the hydrogenation substrate (1 mmol), anhydrous degassed solvent (7 mL) and the metal complex pre-catalyst (0.01 mmol). After 10 cycles of evacuation and filling with hydrogen, the autoclave was pressurised to an appropriate initial pressure of hydrogen. The reaction mixture was stirred at room temperature and after the appropriate time the autoclave was opened, the reaction mixture was filtered through silica gel, concentrated and the residue was analysed by enantioselective GC.
With chloro(1,5-cyclooctadiene)rhodium(I) dimer; (2S,4S)-N-butoxycarbonyl-4-diphenylphosphino-2-diphenylphosphinomethylpyrrolidine; In methanol; at 30℃; under 825.083 Torr;Catalytic behavior; General procedure: The set up of the hydrogenation apparatus [22,23] is shown in Scheme 4. About 1.0-1.4 g of the yellow-orange sol gel immobilized catalyst, a desired amount of substrate and 95 mL of solvent (methanol, water or aqueous-micellar solution) were added to a stirred tank reactor and stirred at 400 rpm under N2-atmosphere at the desired reaction temperature. The N2 was replaced by H2 (p = 1.1 × 105 Pa) without stirring and the reaction was started by turning the stirrer on 800 rpm again. The reactions were performed in semi-batch mode with hydrogen being permanently added to the stirred tank reactor to achieve a constant total pressure of 1.1 × 105 Pa in reactor. The cumulative hydrogen consumption and the pressure during the reaction were recorded using a Bronkhorst flow meter and pressure controller (Bronkhorst Maettig GmbH, Kamen, Germany), respectively (see Scheme 4). The sensitivity of measured hydrogen consumption was ±0.4 mL. The pressure and the hydrogen flow during the reaction were registered and analyzed on a PC, from these results the substrate concentration csubstrate and the conversion X were calculated.

Reference: [1]Heterocycles,1981,vol. 15,p. 1023 - 1026
[2]Tetrahedron Asymmetry,1994,vol. 5,p. 675 - 690
[3]Heterocycles,1981,vol. 15,p. 1023 - 1026
[4]Journal of the American Chemical Society,1996,vol. 118,p. 5897 - 5903
[5]Bulletin of the Chemical Society of Japan,1989,vol. 62,p. 942 - 944
[6]Synthesis,1989,p. 743 - 745
[7]Tetrahedron Letters,1994,vol. 35,p. 8705 - 8708
[8]Journal of Organic Chemistry,1980,vol. 45,p. 4728 - 4739
[9]Tetrahedron Letters,1991,vol. 32,p. 3671 - 3672
[10]Chemistry Letters,1987,p. 1921 - 1922
[11]Tetrahedron Letters,1994,vol. 35,p. 8701 - 8704
[12]Journal of Organometallic Chemistry,1998,vol. 557,p. 117 - 120
[13]Journal of Organic Chemistry,1980,vol. 45,p. 4728 - 4739
[14]Tetrahedron Letters,1991,vol. 32,p. 3671 - 3672
[15]Journal of the American Chemical Society,1993,vol. 115,p. 152 - 159
[16]Journal of Organometallic Chemistry,1985,vol. 279,p. 5 - 22
[17]Journal of the American Chemical Society,2000,vol. 122,p. 11539 - 11540
[18]Angewandte Chemie - International Edition,2002,vol. 41,p. 612 - 614
[19]Tetrahedron Asymmetry,2002,vol. 13,p. 1817 - 1824
[20]European Journal of Organic Chemistry,2003,p. 3453 - 3459
[21]Helvetica Chimica Acta,2006,vol. 89,p. 1716 - 1729
[22]Organic Letters,2003,vol. 5,p. 205 - 207
[23]Advanced Synthesis and Catalysis,2003,vol. 345,p. 308 - 323
[24]Advanced Synthesis and Catalysis,2004,vol. 346,p. 1263 - 1266
[25]Patent: US2006/47128,2006,A1 .Location in patent: Page/Page column 21-22
[26]Organic Letters,2007,vol. 9,p. 5557 - 5560
[27]Patent: US2010/22800,2010,A1 .Location in patent: Page/Page column 15
[28]Patent: US2007/100152,2007,A1 .Location in patent: Page/Page column 24
[29]Advanced Synthesis and Catalysis,2012,vol. 354,p. 3025 - 3035
[30]Journal of Molecular Catalysis A: Chemical,2013,vol. 366,p. 359 - 367
  • 10
  • [ 5673-98-3 ]
  • [ 2174-58-5 ]
  • 11
  • [ 75371-84-5 ]
  • [ 2174-58-5 ]
  • 13
  • [ 197852-81-6 ]
  • [ 2174-58-5 ]
  • 14
  • [ 498-24-8 ]
  • [ 2174-58-5 ]
  • 15
  • [ 597-44-4 ]
  • [ 2174-58-5 ]
  • [ 6236-10-8 ]
  • 17
  • methyllycaconitine [ No CAS ]
  • [ 2174-58-5 ]
  • [ 26000-17-9 ]
  • 18
  • (S)-2-Ethoxycarbonyl-3-methyl-succinic acid diethyl ester [ No CAS ]
  • [ 2174-58-5 ]
  • 20
  • [ 192060-40-5 ]
  • [ 3641-51-8 ]
  • [ 2174-58-5 ]
  • 21
  • [ 2174-58-5 ]
  • 2-Amino-benzoic acid (1R,4S,7R,8R,9R)-3-ethyl-9-methoxy-3-aza-tricyclo[5.4.0.04,8]undec-1-ylmethyl ester [ No CAS ]
  • 2-((R)-3-Methyl-2,5-dioxo-pyrrolidin-1-yl)-benzoic acid (1R,4S,8R,9R)-3-ethyl-9-methoxy-3-aza-tricyclo[5.4.0.04,8]undec-1-ylmethyl ester [ No CAS ]
  • 24
  • (+-)-methylsuccinic acid [ No CAS ]
  • [ 2174-58-5 ]
  • 25
  • [ 498-21-5 ]
  • acidic strychnine salt [ No CAS ]
  • [ 2174-58-5 ]
  • 26
  • [ 3377-31-9 ]
  • [ 3641-51-8 ]
  • [ 2174-58-5 ]
  • 27
  • [ 2174-58-5 ]
  • 2-Amino-benzoic acid (4aR,8S,8aS)-2-methyl-decahydro-isoquinolin-8-yl ester [ No CAS ]
  • 2-((R)-3-Methyl-2,5-dioxo-pyrrolidin-1-yl)-benzoic acid (4aS,8R,8aR)-2-methyl-decahydro-isoquinolin-8-yl ester [ No CAS ]
  • 28
  • [ 2174-58-5 ]
  • 2-Amino-benzoic acid (4aR,8R,8aS)-2-methyl-decahydro-isoquinolin-8-yl ester [ No CAS ]
  • 2-((R)-3-Methyl-2,5-dioxo-pyrrolidin-1-yl)-benzoic acid (4aS,8S,8aR)-2-methyl-decahydro-isoquinolin-8-yl ester [ No CAS ]
  • 29
  • [ 2174-58-5 ]
  • 2-Amino-benzoic acid (4aR,8S,8aS)-2-ethyl-decahydro-isoquinolin-8-yl ester [ No CAS ]
  • 2-((R)-3-Methyl-2,5-dioxo-pyrrolidin-1-yl)-benzoic acid (4aS,8R,8aR)-2-ethyl-decahydro-isoquinolin-8-yl ester [ No CAS ]
  • 30
  • [ 2174-58-5 ]
  • 2-Amino-benzoic acid (4aR,8R,8aS)-2-ethyl-decahydro-isoquinolin-8-yl ester [ No CAS ]
  • 2-((R)-3-Methyl-2,5-dioxo-pyrrolidin-1-yl)-benzoic acid (4aS,8S,8aR)-2-ethyl-decahydro-isoquinolin-8-yl ester [ No CAS ]
  • 31
  • [ 2749-11-3 ]
  • [ 2174-58-5 ]
  • [ 620627-28-3 ]
  • (S)-1-((S)-2-Hydroxy-1-methyl-ethyl)-3-methyl-pyrrolidine-2,5-dione [ No CAS ]
  • 32
  • [ 35320-23-1 ]
  • [ 2174-58-5 ]
  • (R)-1-((R)-2-Hydroxy-1-methyl-ethyl)-3-methyl-pyrrolidine-2,5-dione [ No CAS ]
  • (S)-1-((R)-2-Hydroxy-1-methyl-ethyl)-3-methyl-pyrrolidine-2,5-dione [ No CAS ]
  • 33
  • [ 2174-58-5 ]
  • [ 108-24-7 ]
  • [ 6973-20-2 ]
  • 34
  • 2-methyl-pentane-1,4-diol [ No CAS ]
  • [ 2174-58-5 ]
  • 37
  • [ 2174-58-5 ]
  • (2S,3R)-3-(3-hydroxyphenyl)-2-[4-({(2S)-2-[(3R)-3-methylpyrrolidin-1-yl]propyl}oxy) phenyl]-2,3-dihydro-1,4-benzoxathiin-6-ol [ No CAS ]
  • 38
  • [ 2174-58-5 ]
  • (2S,3R)-3-(4-hydroxyphenyl)-2-[4-({(2S)-2-[(3R)-3-methylpyrrolidin-1-yl] propyl}oxy)phenyl]-2,3-dihydro-1,4-benzoxathiin-6-ol [ No CAS ]
  • 39
  • [ 2174-58-5 ]
  • (2S,3R)-3-(4-hydroxyphenyl)-2-[4-({(2S)-2-[(3S)-3-methylpyrrolidin-1-yl]propyl}oxy) phenyl]-2,3-dihydro-1,4-benzoxathiin-6-ol [ No CAS ]
  • 40
  • [ 2174-58-5 ]
  • (2S,3R)-3-(4-Hydroxy-phenyl)-2-{4-[(R)-2-((R)-3-methyl-pyrrolidin-1-yl)-propoxy]-phenyl}-2,3-dihydro-benzo[1,4]oxathiin-6-ol [ No CAS ]
  • 41
  • [ 2174-58-5 ]
  • (2S,3R)-3-(4-hydroxyphenyl)-2-[4-({(2R)-2-[(3S)-3-methylpyrrolidin-1-yl]propyl}oxy)phenyl]-2,3-dihydro-1,4-benzoxathiin-6-ol [ No CAS ]
  • 42
  • [ 2174-58-5 ]
  • (2S,3R)-5-fluoro-3-(4-hydroxyphenyl)-2-[4-({(2S)-2-[(3R)-3-methylpyrrolidin-1-yl] propyl}oxy)phenyl]-2,3-dihydro-1,4-benzoxathiin-6-ol [ No CAS ]
  • 43
  • [ 2174-58-5 ]
  • (2S,3R)-5-fluoro-3-(3-hydroxyphenyl)-2-[4-({(2S)-2-[(3R)-3-methylpyrrolidin-1-yl] propyl}oxy)phenyl]-2,3-dihydro-1,4-benzoxathiin-6-ol [ No CAS ]
  • 44
  • [ 2174-58-5 ]
  • (2S,3R)-2-{4-[(S)-2-((R)-3-Methyl-pyrrolidin-1-yl)-propoxy]-phenyl}-3-(4-triisopropylsilanyloxy-phenyl)-2,3-dihydro-benzo[1,4]oxathiin-6-ol [ No CAS ]
  • 45
  • [ 2174-58-5 ]
  • (2S,3R)-2-{4-[(S)-2-((S)-3-Methyl-pyrrolidin-1-yl)-propoxy]-phenyl}-3-(4-triisopropylsilanyloxy-phenyl)-2,3-dihydro-benzo[1,4]oxathiin-6-ol [ No CAS ]
  • 46
  • [ 2174-58-5 ]
  • (2S,3R)-2-{4-[(R)-2-((R)-3-Methyl-pyrrolidin-1-yl)-propoxy]-phenyl}-3-(4-triisopropylsilanyloxy-phenyl)-2,3-dihydro-benzo[1,4]oxathiin-6-ol [ No CAS ]
  • 47
  • [ 2174-58-5 ]
  • (2S,3R)-2-{4-[(R)-2-((S)-3-Methyl-pyrrolidin-1-yl)-propoxy]-phenyl}-3-(4-triisopropylsilanyloxy-phenyl)-2,3-dihydro-benzo[1,4]oxathiin-6-ol [ No CAS ]
  • 48
  • [ 2174-58-5 ]
  • (2S,3R)-2-{4-[(S)-2-((R)-3-Methyl-pyrrolidin-1-yl)-propoxy]-phenyl}-3-(3-triisopropylsilanyloxy-phenyl)-2,3-dihydro-benzo[1,4]oxathiin-6-ol [ No CAS ]
  • 49
  • [ 2174-58-5 ]
  • (2S,3R)-5-Fluoro-2-{4-[(S)-2-((R)-3-methyl-pyrrolidin-1-yl)-propoxy]-phenyl}-3-(3-triisopropylsilanyloxy-phenyl)-2,3-dihydro-benzo[1,4]oxathiin-6-ol [ No CAS ]
  • 50
  • [ 2174-58-5 ]
  • (2S,3R)-5-Fluoro-2-{4-[(S)-2-((R)-3-methyl-pyrrolidin-1-yl)-propoxy]-phenyl}-3-(4-triisopropylsilanyloxy-phenyl)-2,3-dihydro-benzo[1,4]oxathiin-6-ol [ No CAS ]
  • 53
  • [ 2174-58-5 ]
  • (R)-1-((R)-2-{4-[(2S,3R)-6-Benzyloxy-3-(4-triisopropylsilanyloxy-phenyl)-2,3-dihydro-benzo[1,4]oxathiin-2-yl]-phenoxy}-1-methyl-ethyl)-3-methyl-pyrrolidine [ No CAS ]
  • 54
  • [ 2174-58-5 ]
  • (S)-1-((R)-2-{4-[(2S,3R)-6-Benzyloxy-3-(4-triisopropylsilanyloxy-phenyl)-2,3-dihydro-benzo[1,4]oxathiin-2-yl]-phenoxy}-1-methyl-ethyl)-3-methyl-pyrrolidine [ No CAS ]
  • 56
  • [ 2174-58-5 ]
  • (R)-1-((S)-2-{4-[(2S,3R)-6-Benzyloxy-5-fluoro-3-(4-triisopropylsilanyloxy-phenyl)-2,3-dihydro-benzo[1,4]oxathiin-2-yl]-phenoxy}-1-methyl-ethyl)-3-methyl-pyrrolidine [ No CAS ]
  • 57
  • [ 2174-58-5 ]
  • (R)-1-((S)-2-{4-[(2S,3R)-6-Benzyloxy-5-fluoro-3-(3-triisopropylsilanyloxy-phenyl)-2,3-dihydro-benzo[1,4]oxathiin-2-yl]-phenoxy}-1-methyl-ethyl)-3-methyl-pyrrolidine [ No CAS ]
  • 74
  • [ 2174-58-5 ]
  • (S)-3-Amino-N-[(S)-1-((3R,4S)-1,4-dimethyl-2,5-dioxo-pyrrolidine-3-carbonyl)-2-methyl-propyl]-3-phenyl-propionamide [ No CAS ]
  • 75
  • [ 2174-58-5 ]
  • (S)-3-Amino-N-[(S)-2-methyl-1-((3R,4S)-4-methyl-1-methylamino-2,5-dioxo-pyrrolidine-3-carbonyl)-propyl]-3-phenyl-propionamide [ No CAS ]
  • 76
  • [ 2174-58-5 ]
  • (S)-3-Amino-N-[(S)-1-((3R,4S)-1-ethoxy-4-methyl-2,5-dioxo-pyrrolidine-3-carbonyl)-2-methyl-propyl]-3-phenyl-propionamide [ No CAS ]
  • 77
  • [ 2174-58-5 ]
  • (S)-3-Amino-N-[(S)-1-((3R,4S)-1-dimethylamino-4-methyl-2,5-dioxo-pyrrolidine-3-carbonyl)-2-methyl-propyl]-3-phenyl-propionamide [ No CAS ]
  • 78
  • [ 2174-58-5 ]
  • (S)-3-Amino-N-{(S)-1-[(3R,4S)-1-(2-methoxy-ethyl)-4-methyl-2,5-dioxo-pyrrolidine-3-carbonyl]-2-methyl-propyl}-3-phenyl-propionamide [ No CAS ]
  • 79
  • [ 2174-58-5 ]
  • (S)-3-Amino-N-[(S)-1-((3R,4S)-1-cyclopropyl-4-methyl-2,5-dioxo-pyrrolidine-3-carbonyl)-2-methyl-propyl]-3-phenyl-propionamide [ No CAS ]
  • 81
  • [ 2174-58-5 ]
  • {(S)-2-[(S)-1-((3R,4S)-1,4-Dimethyl-2,5-dioxo-pyrrolidine-3-carbonyl)-2-methyl-propylcarbamoyl]-1-phenyl-ethyl}-carbamic acid tert-butyl ester [ No CAS ]
  • 83
  • [ 2174-58-5 ]
  • {(S)-2-[(S)-2-Methyl-1-((3R,4S)-4-methyl-1-methylamino-2,5-dioxo-pyrrolidine-3-carbonyl)-propylcarbamoyl]-1-phenyl-ethyl}-carbamic acid tert-butyl ester [ No CAS ]
  • 84
  • [ 2174-58-5 ]
  • (2E,4E)-Hexa-2,4-dienoic acid {(S)-2-[(S)-1-((3R,4S)-1,4-dimethyl-2,5-dioxo-pyrrolidine-3-carbonyl)-2-methyl-propylcarbamoyl]-1-phenyl-ethyl}-amide [ No CAS ]
  • 85
  • [ 2174-58-5 ]
  • {(S)-2-[(S)-1-((3R,4S)-1-Dimethylamino-4-methyl-2,5-dioxo-pyrrolidine-3-carbonyl)-2-methyl-propylcarbamoyl]-1-phenyl-ethyl}-carbamic acid tert-butyl ester [ No CAS ]
  • 86
  • [ 2174-58-5 ]
  • {(S)-2-[(S)-1-((3R,4S)-1-Ethoxy-4-methyl-2,5-dioxo-pyrrolidine-3-carbonyl)-2-methyl-propylcarbamoyl]-1-phenyl-ethyl}-carbamic acid tert-butyl ester [ No CAS ]
  • 87
  • [ 2174-58-5 ]
  • (E)-3-{(S)-2-[(S)-2-Methyl-1-((3R,4S)-4-methyl-2,5-dioxo-pyrrolidine-3-carbonyl)-propylcarbamoyl]-1-phenyl-ethylcarbamoyl}-acrylic acid [ No CAS ]
  • 88
  • [ 2174-58-5 ]
  • ((S)-2-{(S)-1-[(3R,4S)-1-(2-Methoxy-ethyl)-4-methyl-2,5-dioxo-pyrrolidine-3-carbonyl]-2-methyl-propylcarbamoyl}-1-phenyl-ethyl)-carbamic acid tert-butyl ester [ No CAS ]
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 2174-58-5 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 597-43-3

[ 597-43-3 ]

2,2-Dimethylsuccinic acid

Similarity: 0.95

Chemical Structure| 923-42-2

[ 923-42-2 ]

Butane-1,2,4-tricarboxylic acid

Similarity: 0.95

Chemical Structure| 50905-10-7

[ 50905-10-7 ]

2-Butyloctanedioic acid

Similarity: 0.95

Chemical Structure| 19766-89-3

[ 19766-89-3 ]

Sodium 2-ethylhexanoate

Similarity: 0.90

Chemical Structure| 3164-85-0

[ 3164-85-0 ]

Potassium 2-ethylhexanoate

Similarity: 0.90

Carboxylic Acids

Chemical Structure| 1460-16-8

[ 1460-16-8 ]

Cycloheptane carboxylic acid

Similarity: 0.95

Chemical Structure| 99-14-9

[ 99-14-9 ]

Propane-1,2,3-tricarboxylic acid

Similarity: 0.95

Chemical Structure| 597-43-3

[ 597-43-3 ]

2,2-Dimethylsuccinic acid

Similarity: 0.95

Chemical Structure| 923-42-2

[ 923-42-2 ]

Butane-1,2,4-tricarboxylic acid

Similarity: 0.95

Chemical Structure| 50905-10-7

[ 50905-10-7 ]

2-Butyloctanedioic acid

Similarity: 0.95